Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	answering member constituency
creator	label
publisher
tabling member	label

Search

1309801

	human indexable
	published
	registered interest
	answer date	20/04/2021
	date	16/04/2021
	date tabled	16/04/2021
	ddp created	16/04/2021 14:13:41
	answering body	Department for Business, Energy and Industrial Strategy
	question status	Tabled
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	ddp modified	20/04/2021 09:55:13 27/04/2021 16:36:08
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	182110
	legislature	25259
	parliament number	58
	question first answered	27/04/2021 16:04:47
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many Oxford/AstraZenica vaccines were exported from the UK to Australia in late February and early March 2021.
	session	2019/21
	session number	1
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2019/21 182110
	type	WrittenParliamentaryQuestion
	uin	182110
	version	2
	written parliamentary question type	Ordinary
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1327494

	human indexable
	published
	registered interest
	answer date	26/05/2021
	date	24/05/2021
	date tabled	24/05/2021
	ddp created	24/05/2021 22:19:54
	answering body	Department for Business, Energy and Industrial Strategy
	question status	Tabled
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	ddp modified	25/05/2021 13:55:12 02/06/2021 07:44:06
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	6500
	legislature	25259
	parliament number	58
	question first answered	02/06/2021 07:13:05
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many people volunteered to participate in Novavax trials.
	session	2021/22
	session number	2
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2021/22 6500
	type	WrittenParliamentaryQuestion
	uin	6500
	version	2
	written parliamentary question type	Ordinary
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1327500

	human indexable
	published
	registered interest
	answer date	27/05/2021
	date	24/05/2021
	date tabled	24/05/2021
	ddp created	24/05/2021 22:20:11
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/05/2021 22:38:20 02/06/2021 09:25:09
	hansard heading	NHS Covid Pass: Clinical Trials
	house id	1
	identifier	6504
	legislature	25259
	parliament number	58
	question first answered	02/06/2021 08:53:15
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of people are not eligible for the proposed vaccination passports due to their participation in the Novavax trial.
	session	2021/22
	session number	2
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2021/22 6504
	type	WrittenParliamentaryQuestion
	uin	6504
	version	1
	written parliamentary question type	NamedDay
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1327496

	human indexable
	published
	registered interest
	answer date	26/05/2021
	date	24/05/2021
	date tabled	24/05/2021
	ddp created	24/05/2021 22:20:00
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/05/2021 22:38:10 28/06/2021 14:24:07
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	6501
	legislature	25259
	parliament number	58
	question first answered	28/06/2021 13:52:48
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of people in the UK have been delayed from receiving any covid-19 vaccine because they have participated in the Novavax trials.
	session	2021/22
	session number	2
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2021/22 6501
	type	WrittenParliamentaryQuestion
	uin	6501
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1309797

	human indexable
	published
	registered interest
	answer date	20/04/2021
	date	16/04/2021
	date tabled	16/04/2021
	ddp created	16/04/2021 14:13:29
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/04/2021 14:18:56 26/04/2021 16:23:08
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	182107
	legislature	25259
	parliament number	58
	question first answered	26/04/2021 15:51:44
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 March 2019 to Question 166586 on Coronavirus: Vaccination, since the Joint Committee on Vaccination and Immunisation advised that local teams should consider a universal offer to adults experiencing homelessness and rough sleeping alongside people in priority group six, how many homeless people in the UK have received a covid-19 vaccine.
	session	2019/21
	session number	1
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2019/21 182107
	type	WrittenParliamentaryQuestion
	uin	182107
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1343883

	human indexable
	published
	registered interest
	answer date	07/07/2021
	date	05/07/2021
	date tabled	05/07/2021
	ddp created	05/07/2021 22:06:15
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	05/07/2021 22:28:03 13/07/2021 16:05:15
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	27365
	legislature	25259
	parliament number	58
	question first answered	13/07/2021 15:33:36
	question text	To ask the Secretary of State for Health and Social Care, what (a) advice and (b) support his Department is providing to Novavax covid-19 vaccine trial participants who have been unblinded but do not have access to their antibody test results and are unsure of their level of protection against the covid-19 virus.
	session	2021/22
	session number	2
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2021/22 27365
	type	WrittenParliamentaryQuestion
	uin	27365
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1284909

	human indexable
	published
	registered interest
	answer date	11/02/2021
	date	08/02/2021
	date tabled	08/02/2021
	ddp created	08/02/2021 22:39:09
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/02/2021 22:56:45 12/03/2021 15:12:08
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	150966
	legislature	25259
	parliament number	58
	question first answered	12/03/2021 14:40:36
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) potential merits of including ME/CFS on the list of neurological conditions in group 6 of the JCVI priority list and (b) consistency of GP decisions on including ME/CFS patients in group 6.
	session	2019/21
	session number	1
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2019/21 150966
	type	WrittenParliamentaryQuestion
	uin	150966
	version	1
	written parliamentary question type	NamedDay
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1300685

	human indexable
	published
	registered interest
	answer date	12/03/2021
	date	09/03/2021
	date tabled	09/03/2021
	ddp created	09/03/2021 19:49:28
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	10/03/2021 09:15:20 12/03/2021 14:41:08
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	165694
	legislature	25259
	parliament number	58
	question first answered	12/03/2021 14:09:44
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of including inclusion of Myalgic encephalomyelitis in the group 6 specified conditions for covid-19 vaccination; and what estimate he has made of the number of people with that condition who have received a covid-19 vaccination.
	session	2019/21
	session number	1
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2019/21 165694
	type	WrittenParliamentaryQuestion
	uin	165694
	version	2
	written parliamentary question type	NamedDay
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1301313

	human indexable
	published
	registered interest
	answer date	15/03/2021
	date	10/03/2021
	date tabled	10/03/2021
	ddp created	10/03/2021 20:29:51
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	10/03/2021 20:39:43 15/03/2021 17:32:07
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	166587
	legislature	25259
	parliament number	58
	question first answered	15/03/2021 17:00:48
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of homeless people that have been vaccinated up to 10 March 2021.
	session	2019/21
	session number	1
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2019/21 166587
	type	WrittenParliamentaryQuestion
	uin	166587
	version	1
	written parliamentary question type	NamedDay
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra

1343882

	human indexable
	published
	registered interest
	answer date	07/07/2021
	date	05/07/2021
	date tabled	05/07/2021
	ddp created	05/07/2021 22:06:10
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	05/07/2021 22:28:00 13/07/2021 16:05:17
	hansard heading	Coronavirus: Vaccination
	house id	1
	identifier	27364
	legislature	25259
	parliament number	58
	question first answered	13/07/2021 15:33:36
	question text	To ask the Secretary of State for Health and Social Care, what guidance his Department provides to Novavax covid-19 vaccine trial participants who have been unblinded and received two vaccine doses under that trial over six months ago on whether they should receive an approved covid-19 vaccination.
	session	2021/22
	session number	2
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	title	House of Commons Tabled Parliamentary Question 2021/22 27364
	type	WrittenParliamentaryQuestion
	uin	27364
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member constituency Stratford-on-Avon
	creator	4811 label Biography information for Navendu Mishra
	publisher	25259
	tabling member	4811 label Biography information for Navendu Mishra